Delivery Order SPE2DB24D9227-SPE2DB25FANKS
- Not listed
- The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Botox 100 unit vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $500 million and...
- The U.S. Defense Logistics Agency issued a delivery order valued at $67,919.25 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order was awarded on September 15, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. The award represents...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for BOTOX 200 Unit Vials, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a purchase order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a $5,508.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on May 13, 2025, with an ultimate completion date of June 4, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $19,405.50 on August 21, 2025, for the supply of Botox 200 Unit Vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 12, 2025. The contract employs firm fixed-price pricing with no set-aside designation, allowing the vendor to compete directly in the federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 unit vials. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its location in Park Ridge, IL. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,312.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of September 24, 2025, and represents a specific fulfillment under the company's broader procurement...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Botox 200 unit vials valued at $7,115.35. This firm fixed-price delivery order represents a single procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and extending through November 2026. The order is set to complete by October 21, 2025, with fulfillment occurring from the vendor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a $22,203.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Botox 100-unit vials, with an ultimate completion date of September 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS's larger single-award Indefinite Delivery Contract with DLA...
- SPE2DB24D9227Indefinite Delivery Contract
- SPE2DB24D9227-SPE2DB25FANKSDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,762.20 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion indefinite delivery vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, holding a robust portfolio of contract awards with the Defense Logistics Agency for diverse medical products spanning prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's core business involves distributing branded and generic drugs, over-the-counter medications, and medical consumables to Department of Defense healthcare sites across the country. This particular delivery order for BOTOX reflects the vendor's specialized capability in providing high-value pharmaceutical products that support the medical supply needs of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 9/26/25 |